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PREVALENCE OF ANTIBODIES TO NEOSPORA CANINUM, SARCOCYSTIS NEURONA,
AND TOXOPLASMA GONDII IN WILD HORSES FROM CENTRAL WYOMING
J. P. Dubey, S. M. Mitchell*, J. K. Morrow†, J. C. Rhyan‡, L. M. Stewart§, D. E. Granstrom, S. Romand\, P. Thulliez\,
W. J. Saville#, and D. S. Lindsay*
Animal Parasitic Diseases Laboratory, Animal and Natural Resources Institute, Agricultural Research Service, United States Department of
Agriculture, Building 1001, Beltsville, Maryland 20705-2350. e-mail: jdubey@anri.barc.usda.gov
ABSTRACT: Sarcocystis neurona, Neospora caninum, N. hughesi, and Toxoplasma gondii are 4 related coccidians considered
to be associated with encephalomyelitis in horses. The source of infection for N. hughesi is unknown, whereas opossums,
dogs, and cats are the definitive hosts for S. neurona, N. caninum, and T. gondii, respectively. Seroprevalence of these
coccidians in 276 wild horses from central Wyoming outside the known range of the opossum (Didelphis virginiana) was
determined. Antibodies to T. gondii were found only in 1 of 276 horses tested with the modified agglutination test using 1:
25, 1:50, and 1:500 dilutions. Antibodies to N. caninum were found in 86 (31.1%) of the 276 horses tested with the Neospora
agglutination test—the titers were 1:25 in 38 horses, 1:50 in 15, 1:100 in 9, 1:200 in 8, 1:400 in 4, 1:800 in 2, 1:1,600 in 2,
1:3,200 in 2, and 1:12,800 in 1. Antibodies to S. neurona were assessed with the serum immunoblot; of 276 horses tested,
18 had antibodies considered specific for S. neurona. Antibodies to S. neurona also were assessed with the S. neurona direct
agglutination test (SAT). Thirty-nine of 265 horses tested had SAT antibodies—in titers of 1:50 in 26 horses and 1:100 in 13.
The presence of S. neurona antibodies in horses in central Wyoming suggests that either there is cross-reactivity between S.
neurona and some other infection or a definitive host other than opossum is the source of infection. In a retrospective study,
S. neurona antibodies were not found by immunoblot in the sera of 243 horses from western Canada outside the range of D.
virginiana.
Sarcocystis neurona, Neospora caninum, N. hughesi, and
Toxoplasma gondii are related coccidians that are reported to
cause encephalitis in horses. Of these 4 parasites, S. neurona is
the most frequent cause of equine protozoal myeloencephalitis
(EPM) in horses in the United States (Dubey et al., 1991; Dub-
ey, Lindsay et al., 2001). The opossum (Didelphis virginiana)
is the only known definitive host for S. neurona in the United
States, and the distribution of EPM coincides with the geo-
graphic range of D. virginiana. Horses become infected by in-
gesting S. neurona oocysts or sporocysts excreted in feces of
the opossum (Fenger et al., 1997; Dubey and Lindsay, 1998).
More than 30% of horses tested in the United States were found
to have antibodies to S. neurona by using immunoblot tests
(IBTs) (Bentz et al., 1997; Blythe et al., 1997; Saville et al.,
1997; Tillotson et al., 1999; Rossano et al., 2001; Daft et al.,
2002).
Antibodies to N. caninum or N. hughesi or both were found
in 23.3% of 296 horses from 2 meat packing plants in Nebraska
and Texas (Dubey, Romand et al., 1999), in 11.5% of 536 hors-
es in Alabama (Cheadle et al., 1999), in 11% of 208 horses
from Missouri (Vardeleon et al., 2001), and in 23% of 99 horses
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from France (Pitel et al., 2001). Clinical neosporosis has been
reported in a few horses only (Dubey and Porterfield, 1990;
Daft et al., 1996; Gray et al., 1996; Lindsay et al., 1996; Marsh
et al., 1996; Hamir et al., 1998; Cheadle et al., 1999; Pronost
et al., 1999). The domestic dog (Canis familiaris) is the only
known definitive host for N. caninum (McAllister et al., 1998);
the definitive host for N. hughesi is unknown. Although Neos-
pora spp. can be transmitted congenitally in horses (Dubey and
Porterfield, 1990; Pronost et al., 1999), congenital equine neo-
sporosis is considered a rare occurrence.
Before the discovery of S. neurona and N. caninum, clinical
cases of EPM in horses were misdiagnosed as toxoplasmosis
(reviewed in Dubey and Beattie, 1988; Dubey, Kerber et al.,
1999). Compared with S. neurona and N. caninum, the sero-
prevalence of T. gondii in horses is low, and there is no proven
case of clinical toxoplasmosis in horses. Antibodies to T. gondii
were found in 6.9% of the 1,000 horses from the United States
(Dubey, Thulliez et al., 1999). Felids are the definitive hosts
for T. gondii (Dubey and Beattie, 1988).
The objective of the present study was to determine the se-
roprevalence of S. neurona, N. caninum, and T. gondii in wild
horses from central Wyoming, outside the known geographic
range of the opossum.
MATERIALS AND METHODS
Wild horses from Wyoming
Serum samples were obtained from 276 wild horses stationed at Hon-
or Farms, near Riverton in central Wyoming (latitude 438019300N, lon-
gitude 1088229300 N). These horses were caught in the wild and kept
on this farm before private adoption. The average stay of horses on this
farm was no more than 4 mo. While on the farm, horses were fed alfalfa
hay and occasionally grain grown on the farm. Opossums have not been
observed in this area or in the areas from which the horses were cap-
tured. Data regarding approximate age and sex were available for most
horses. One hundred and thirty-seven females and 139 males were in-
cluded.
Serologic testing
Blood samples were obtained from a jugular vein, and serum samples
were sent to the Animal Parasitic Diseases Laboratory (APDL), United
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Total 276 38 15 9 8 16 86
TABLE II. Data on 18 horses with confirmed antibodies to Sarcocystis
neurona detected by immunoblot.
Horse no. Age




























































































*NAT 5 Neospora agglutination test, SAT 5 Sarcocystis neurona agglutination
test, MAT 5 Toxoplasma gondii modified agglutination test.
States Department of Agriculture, Beltsville, Maryland, for serologic
testing.
Antibodies to T. gondii and N. caninum were determined at APDL
using direct agglutination tests. For T. gondii, sera were diluted 1:25,
1:50, and 1:500 and tested with the modified T. gondii agglutination
test (MAT), according to a previously published protocol (Dubey and
Desmonts, 1987). For N. caninum, sera were initially screened at 1:25,
1:50, and 1:500 dilutions using Neospora agglutination test (NAT), as
described by Romand et al. (1998). Seropositive samples were titrated
2-fold, starting at 1:100 dilution.
Antibodies to S. neurona were determined by immunoblots as de-
scribed (Granstrom et al., 1993; Dubey, Lindsay et al., 2001) and by S.
neurona direct agglutination test (SAT) as described by Lindsay and
Dubey (2001). The SAT was performed at the Center for Molecular
Medicine and Infectious Diseases, Virginia Tech, Blacksburg, Virginia.
The immunoblots were performed at Equine Biodiagnostics Inc. (EBI),
Lexington, Kentucky. Antibodies (immunoglobulin G, IgG) to S. neu-
rona were essentially detected by immunoblot as described previously
(Granstrom et al., 1993). Essentially, lysates of merozoites were sub-
jected to electrophoresis through denaturing gradient polyacrylamide
gels (sodium dodecyl sulfate, 10–20% polyacrylamide gel electropho-
resis). After electrophoresis, separated proteins were electrically trans-
ferred to nitrocellulose paper by standard methods. Equine sera were
incubated with the blot individually, and anti–S. neurona antibodies
were detected using biotinylated anti-equine IgG followed by streptav-
idin–peroxidase conjugate and aminoethyl carbazole peroxide chroma-
gen substrate.
Domestic horses from western Canada
During the course of studies on pathogenesis of S. neurona infection
in horses (Saville et al., 2001; Sofaly et al., 2002), 243 horses from the
Saskatchewan and Manitoba area, Canada, were screened for S. neurona
antibodies to obtain negative horses for the experiments. Horses were
obtained from these areas because they are outside the range of D.
virgiana. Results of immunoblots performed on these horses at EBI are
included in the present article.
RESULTS
Wyoming horses
Antibodies to N. caninum were found in 86 (31.1%) of the
276 horses of all ages (Table I). Prevalences in females were
similar to those in males. High antibody titers ($1:400) were
found in 18.6% of 86 seropositive horses; the highest titer was
1:12,800. Antibodies to T. gondii (MAT) were found in 1 horse,
and the titer was only 1:25.
Antibodies to S. neurona were found by immunoblots in 18
of the 276 horses (Table II). By using the SAT, antibodies were
found in 39 horses—in titers of 1:50 in 26 horses and 1:100 in
13. None of the 18 horses positive by immunoblot was positive
by MAT; 6 were positive by NAT, and 7 were positive by SAT.
Additionally, 15 horses exhibited equivocal (reported as weak)
reactivity by immunoblot analysis. An illustration of the diver-
sity of the immunoblot patterns is shown in a composite im-
munoblot (Fig. 1).
Canadian horses
Among the 243 horses from western Canada, immunoblot
analyses were negative for 219 horses (90.1%), weakly positive
for 20 (8.2%), and confirmed positive for 4. It was later found
that the 4 horses confirmed seropositive were raised in the Unit-
ed States.
DISCUSSION
Clinical N. caninum and N. hughesi infections have been re-
ported in horses in the United States and France. The distinction
between these 2 parasites is based essentially on molecular
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FIGURE 1. An immunoblot containing sera from a representative se-
lection of the 276 study horses is shown. They were chosen on the basis
of their immunoblot banding patterns and reactivities in the SAT assay.
The Sarcocystis neurona–specific bands are designated by the numbered
arrows to the left of the first lane, and their approximate molecular
weights are based on the migration of standards of known molecular
weight (far left). Band 1 5 14.5 kDa, band 2 5 12 kDa, and band 3 5
,7 kDa. Lanes 15, 16, and 17 contain positive, diluted positive (for
assessing lower detection limit), and negative sera, respectively. Lanes
14 and 18 are blank. Lanes 1–13 contain sera that tested positive by
IBT. The sera in lanes 1, 8, and 11 also had SAT titers of 1:50, 1:100,
and 1:100, respectively. Lanes 19–23 contain sera with equivocal IBT
reactivity. Of these, the serum in lane 20 also had a SAT titer of 1:50.
Lanes 24–38 contain sera that tested negative by IBT. The sera in lanes
24, 25, 27, 28, 29, 30, 31, and 37 had SAT titers of 1:100, 1:50, 1:100,
1:100, 1:100, 1:100, 1:50, and 1:100, respectively. Of the 33 sera shown
in this immunoblot, 15 also had titers in the Neospora agglutination
test, ranging from 1:25 (lanes 8, 10, 12, 23, 31, 36, and 37) to 1:800
(lanes 5 and 30).
characteristics. The presence of shared antigens was demon-
strated by the cross-reactivity in the NAT as well as in the
indirect fluorescent antibody test (Marsh et al., 1996, 1998;
Dubey, Liddell et al., 2001). Therefore, it is not possible to say
whether the antibodies in 31% of wild horses from Wyoming
were due to 1 or both parasites. These data indicate that the
definitive host involved in the life cycle of equine Neospora
spp. infections is present in central Wyoming. The 31% Neo-
spora spp. seropositivity in horses of the present study is the
highest reported to date. Previously, 23% of horses from the
United States (Dubey, Thulliez et al., 1999) and France (Pitel
et al., 2001) were reported to have N. caninum antibodies in
the NAT. Whether the horses aquired Neospora spp. infections
at the farm or in the wild is not known.
The NAT titer that should be considered specific for Neo-
spora spp. infections has not been determined. Therefore, all
titers are presented in the present study. The almost total ab-
sence of detectable T. gondii antibodies in horses with Neo-
spora antibodies demonstrates the specificity of the NAT and
MAT, confirming earlier findings in experimentally infected an-
imals (Romand et al., 1998). Gupta et al. (2002) reported an
indirect fluorescent antibody titer of 1:100 in a horse naturally
infected with N. hughesi; they considered this finding to be the
result of the cross-reactivity between these 2 organisms, but
there is a possibility that the horse may have been exposed to
both parasites.
The antemortem diagnosis of EPM remains a problem. The
IBT was developed to detect the presence of S. neurona–spe-
cific antibodies in serum and cerebrospinal fluid (CSF). Al-
though this test is not perfect, it is the best test available at
present for the diagnosis of S. neurona. The IBT is highly spe-
cific if one considers weak positives as negatives, as supported
by data obtained from Daft et al. (2002) and the present study
with the horses from western Canada. Immunoblots from horses
exposed to S. falcatula infections (Cutler et al., 1999) support
the data on specificity of the IBT.
The lack of any apparent correlation between SAT and im-
munoblot in horses in the present study may be due to these
tests measuring different antibodies. The SAT has not been
evaluated for the diagnosis of EPM in experimentally infected
horses or for use in clinical specimens.
Finding antibodies to S. neurona by immunoblot analysis in
at least 18 horses native to Wyoming is unexpected and unex-
plained. Opossums are not known to occur in central Wyoming,
and there has not been any confirmed case of EPM from horses
native to Wyoming. Cross-reactivity with N. caninum was un-
likely because 9 horses positive by S. neurona immunoblot had
no detectable N. caninum antibody. Pitel et al. (2002) also re-
ported S. neurona antibodies in horses native to France, al-
though opossums do not occur in Europe.
As stated earlier, the IBT was developed by Granstrom et
al. (1993) to detect S. neurona–specific antibodies in the se-
rum and CSF of horses from the Western Hemisphere. This
IBT is not known to cross-react with any related protozoan
in limited investigations. Because it has not been possible to
reliably induce verifiable EPM in horses, the only gold stan-
dard to evaluate the test is the verification of the parasite by
postmortem immunohistochemical examination of the hors-
es. Because it is not possible to rule out the absence of S.
neurona by histologic examination of only a small amount
of central nervous system tissue (in grams), only a positive
identification is meaningful. Recently, Daft et al. (2002) crit-
ically evaluated the performance of IBT in horses with neu-
rologic diseases. They found that IBT was strongly positive
in all 12 horses with confirmed S. neurona infection. More
importantly, 8 horses negative for S. neurona–associated
EPM were infected by other unidentified apicomplexans. Of
these, 5 tested negative by IBT, but sera from 3 had weak
reactivity in the IBT (Daft et al., 2002). It is difficult to in-
terpret the significance of an equivocal result by testing a
given horse at a single time point. For clinical specimens, it
is recommended that a subsequent specimen (4–8 wk later)
be tested and compared with the original result. Whereas
some horses may progress to increased immunoreactivity,
others may remain weak, probably representing a much ear-
lier exposure to the parasite or, possibly, a very low level of
nonspecific reactivity. Marsh et al. (1998) reported S. neu-
rona immunoreactivity in a horse diagnosed with encepha-
litis due to N. hughesi. In light of the findings of the studies
by Daft et al. (2002) and the present study and from the
findings on other naturally infected horses (Dubey, Kerber,
and Granstrom, 1999; Dubey, Venturini et al., 1999) and ex-
perimentally infected rabbits, there is no evidence that S.
neurona–specific antibodies detected by IBT react with
Neospora spp. antigens. It seems most likely that the horse
was exposed to both parasites. The presence of S. neurona–
specific antibodies in horses from central Wyoming is puz-
DUBEY ET AL.—N. CANINUM, S. NEURONA, AND T. GONDII ANTIBODIES IN WILD HORSES 719
zling and suggests that another definitive host may be in-
volved or that the parasite shares antigens with another pro-
tozoan.
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